XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1

Accrued expenses

6 Months Ended

Dec. 31, 2023

Accrued expenses

Accrued expenses

Note 7 – Accrued Expenses

Accrued expenses consisted of the following:

​

​	​	​	​	​	​	​
​		December 31,			June 30,
​	​	2023		​	2023
Personnel and compensation costs	​	$	23,872	​	$	39,060
Consultant	​		6,500	​		4,700
Clinical trial costs due to KMPL	​		150,000	​		100,000
​	​	$	180,372	​	$	143,760

​

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration